Organization
Department of Rheumatology, Cochin Hospital, Paris, France
1 abstract
Abstract
BARICITINIB, AN ORAL JANUS KINASE (JAK)1/JAK2 INHIBITOR, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CDMARD THERAPY: RESULTS OF THE PHASE 3 RA-BUILD STUDY Org: Department of Rheumatology, Cochin Hospital, Paris, France, Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, Province of China, Desert Medical Advances, Palm Desert, United States, Veszprém Csolnoky Ferenc County Hospital, Vészprem, Hungary,